It appears to be safe and triggers an immune response. Those on the trial have developed antibodies and T-cells which fight the virus.
Wits University is collaborating with Oxford in the South African trial.
Let’s get more on this from Professor Shabir Madhi from Wits University joins us now. Courtesy #DStv403